This case demonstrated that first-line treatment with osimertinib could even achieve complete remission of multiple brain metastases comprising as many as twenty lesions of <i>EGFR</i>-mutated NSCLC without radiation therapy. This evidence concerns the gene EGFR and non-small cell lung carcinoma.